Data / Form D filings / MetaStat, Inc.
MetaStat, Inc.: Form D filings
MetaStat, Inc., a biotechnology company in Boston, MA, filed 17 Form D notices with the SEC between 2012 and 2018. The latest, on April 11, 2018, reports $3.4 million sold of a $3.6 million offering to 6 investors.
Find out what MetaStat, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 27 Drydock Avenue, Second Floor, Boston, MA, 02210
- Phone
- (617) 531-6500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1404943
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 11, 2018 | New notice | $3,628,928 | $3,378,928 | $250,000 | 6 | Mar 30, 2018 | sec.gov |
| Jul 5, 2017 | New notice | $7,000,000 | $2,141,001 | $4,858,999 | 14 | Jun 23, 2017 | sec.gov |
| Sep 14, 2016 | New notice | $20,000,000 | $87,500 | $19,912,500 | 1 | Aug 31, 2016 | sec.gov |
| Jun 10, 2016 | New notice | $5,000,000 | $495,000 | $4,505,000 | 11 | May 26, 2016 | sec.gov |
| Feb 22, 2016 | New notice | $1,000,000 | $350,000 | $650,000 | 4 | Feb 12, 2016 | sec.gov |
| Aug 14, 2015 | New notice | $1,200,000 | $1,200,000 | $0 | 1 | Jul 31, 2015 | sec.gov |
| Jan 15, 2015 | New notice | $3,492,500 | $1,257,500 | $2,235,000 | 5 | Dec 31, 2014 | sec.gov |
| Oct 31, 2014 | New notice | $280,693 | $280,693 | $0 | 1 | Oct 24, 2014 | sec.gov |
| Oct 31, 2014 | New notice | $10,000,000 | $0 | $10,000,000 | 1 | Oct 10, 2014 | sec.gov |
| Jul 8, 2014 | New notice | $10,000,000 | $5,735,427 | $4,264,573 | 40 | Jun 30, 2014 | sec.gov |
| Jun 20, 2014 | New notice | $600,000 | $215,000 | $385,000 | 6 | May 22, 2014 | sec.gov |
| Mar 26, 2014 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
| Jan 24, 2014 | New notice | $1,000,000 | $650,000 | $350,000 | 5 | Jan 14, 2014 | sec.gov |
| Dec 24, 2013 | New notice | $500,000 | $500,000 | $0 | 3 | Nov 15, 2013 | sec.gov |
| Dec 24, 2013 | New notice | $1,500,000 | $1,487,000 | $13,000 | 22 | Jan 10, 2013 | sec.gov |
| May 11, 2012 | New notice | $2,000,000 | $880,000 | $1,120,000 | 13 | May 1, 2012 | sec.gov |
| Mar 9, 2012 | New notice | $675,000 | $675,000 | $0 | 8 | Feb 27, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas A. Hamilton | Executive Officer, Director | |
| Paul A. Billings | Director | |
| Daniel H. Schneiderman | Executive Officer | |
| Jerome B. Zeldis | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of Apr 9, 2018 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MetaStat, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.